Issue |
E3S Web of Conf.
Volume 547, 2024
International Conference on Sustainable Green Energy Technologies (ICSGET 2024)
|
|
---|---|---|
Article Number | 03020 | |
Number of page(s) | 6 | |
Section | Energy | |
DOI | https://doi.org/10.1051/e3sconf/202454703020 | |
Published online | 09 July 2024 |
Biocompatible Nanomaterials for Sustainable Biomedical Applications
1 Lovely Professional University, Phagwara, Punjab, India.
2 Uttaranchal University, Dehradun - 248007, India, nehasaini@uumail.in
3 Centre of Research Impact and Outcome, Chitkara University, Rajpura - 140417, Punjab, India, akhilesh.kalia.orp@chitkara.edu.in
4 Chitkara Centre for Research and Development, Chitkara University, Himachal Pradesh - 174103 India, praney.madan.orp@chitkara.edu.in
5 Department of Civil Engineering, GRIET, Hyderabad, Telangana, India
6 G D Goenka University, Haryana, India
* Corresponding author: amit.dutt@lpu.co.in
We explore the many ways biocompatible nanomaterials may be used in sustainable biomedical settings. Quantum dots are 10 nm in size, carbon nanotubes are 50 nm, iron oxide nanoparticles are 25 nm, gold nanoparticles are 20 nm, and silver nanoparticles are 30 nm. The physicochemical features of these nanomaterials are different from one another. These nanomaterials may encapsulate therapeutic substances, according to drug loading evaluations; for example, gold nanoparticles can hold 15 mg/g of iron oxide, 12 mg/g of silver, 18 mg/g of carbon nanotubes, 20 mg/g of carbon, and 10 mg/g of quantum dots. Nanoparticles of gold (95% vitality after 24 hours), silver (93% viability), iron oxide (97% viability), carbon nanotubes (92% viability), and quantum dots (90% viability) highlight the biocompatibility of these materials. Fluorescence intensities of 1000 AU for gold nanoparticles, 980 AU for silver nanoparticles, 1050 AU for iron oxide nanoparticles, 900 AU for carbon nanotubes, and 1100 AU for quantum dots were observed in in vivo imaging investigations, further demonstrating the potential of these nanomaterials as contrast agents. By conducting thorough assessments and analyses, this study reveals how biocompatible nanomaterials can be used to create long-term biomedical applications, such as molecular imaging and targeted drug delivery, which will improve healthcare solutions and patient outcomes.
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.